A reduced national incidence of anogenital warts in young danish men and women after introduction of a national quadrivalent human papillomavirus vaccination programme for young women - An ecological study

Acta Dermato-Venereologica

Volumn 94, Issue 3, 2014, Pages 288-292

  Sandø, Niels ^a   Kofoed, Kristian ^b   Zachariae, Claus ^c   Fouchard, Jan ^a  

^a Danish Health and Medicines Authority   (Denmark)

^b Mental Health Services CPH   (Denmark)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Anogenital warts; Condyloma; Denmark; Herd immunity; Human papillomavirus; Quadrivalent human papillomavirus vaccine

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BEHAVIOR CHANGE; CHLAMYDIASIS; CONDYLOMA ACUMINATUM; FEMALE; HERD IMMUNITY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; POPULATION SIZE; PRIORITY JOURNAL; REGISTER; VACCINATION; WART VIRUS; AGE; CHI SQUARE DISTRIBUTION; CONDYLOMATA ACUMINATA; DENMARK; EPIDEMIOLOGY; IMMUNOLOGY; PROGRAM EVALUATION; SEX DIFFERENCE; SEX RATIO; TIME; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE FACTORS; CHI-SQUARE DISTRIBUTION; CONDYLOMATA ACUMINATA; DENMARK; FEMALE; HUMANS; IMMUNITY, HERD; INCIDENCE; MALE; PAPILLOMAVIRUS VACCINES; PROGRAM EVALUATION; REGISTRIES; SEX DISTRIBUTION; SEX FACTORS; TIME FACTORS; VACCINATION; YOUNG ADULT;

EID: 84899904100     PISSN: 00015555     EISSN: 16512057     Source Type: Journal    
DOI: 10.2340/00015555-1721     Document Type: Article

References (20)

1. Pirotta M, Stein AN, Conway EL, Harrison C, Britt H, Garland S. Genital warts incidence and healthcare resource utilisation in Australia. Sex Transm Infect 2010; 86: 181-186.
2. Langley PC, White DJ, Drake SM. Patterns of treatment and resource utilization in the treatment of external genital warts in England and Wales. Int J STD AIDS 2004; 15: 473-478.
3. Pirotta M, Ung L, Stein A, Conway EL, Mast TC, Fairley CK, Garland S. The psychosocial burden of human papillomavirus related disease and screening interventions. Sex Transm Infect 2009; 85: 508-513.
4. Skaaby S, Kofoed K. Anogenital warts in Danish men who have sex with men. Int J STD AIDS 2011; 22: 214-217.
5. Aubin F, Prétet JL, Jacquard AC, Saunier M, Carcopino X, Jaroud F, et al. Human papillomavirus genotype distribution in external acuminata condylomata: a Large French National Study (EDiTH IV). Clin Infect Dis 2008; 47: 610-615.
6. Brown DR, Schroeder JM, Bryan JT, Stoler MH, Fife KH. Detection of multiple human papillomavirus types in Condylomata acuminata lesions from otherwise healthy and immunosuppressed patients. J Clin Microbiol 1999; 37: 3316-3322.
7. Muñoz N, Manalastas R Jr, Pitisuttithum P, Tresukosol D, Monsonego J, Ault K, et al. Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial. Lancet 2009; 373: 1949-1957.
8. FUTURE I/II Study Group, Dillner J, Kjaer SK, Wheeler CM, Sigurdsson K, Iversen OE, et al. Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial. BMJ 2010; 341: c3493.
9. Garland SM, Hernandez-Avila M, Wheeler CM, Perez G, Harper DM, Leodolter S, et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med 2007; 356: 1928-1943.
10. pro.medicin.dk. Ref Type: Online Source. [accessed Dec 1, 2012].
11. Gravitt PE. The known unknowns of HPV natural history. J Clin Invest 2011; 121: 4593-4599.
12. Oriel JD. Natural history of genital warts. Br J Vener Dis 1971; 47: 1-13.
13. Donovan B, Franklin N, Guy R, Grulich AE, Regan DG, Ali H, et al. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data. Lancet Infect Dis 2011; 11: 39-44.
14. Leval A, Herweijer E, Arnheim-Dahlström L, Walum H, Frans E, Sparén P, Simard JF. Incidence of genital warts in Sweden before and after quadrivalent human papillomavirus vaccine availability. J Infect Dis 2012; 206: 860-866.
15. Read TR, Hocking JS, Chen MY, Donovan B, Bradshaw CS, Fairley CK. The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme. Sex Transm Infect 2011; 87: 544-547.
16. Fairley CK, Hocking JS, Gurrin LC, Chen MY, Donovan B, Bradshaw CS. Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women. Sex Transm Infect 2009; 85: 499-502.
17. Unknown. [Public attitudes, knowledge and behavior in relation to sexuality, STIs and HIV.] 2004. Report in Danish. Available from: www.sst.dk/publ/Publ2004/Undersoeg_ seksualitet_hovedrapp.pdf.
18. Palefsky JM. HPV infection in men. Dis Markers 2007; 23: 261-272.
19. Nyitray AG, Carvalho da Silva RJ, Baggio ML, Smith D, Abrahamsen M, Papenfuss M, et al. Six-month incidence, persistence, and factors associated with persistence of anal human papillomavirus in men: the HPV in men study. J Infect Dis 2011; 204: 1711-1722.
20. Jiang J, Cao N, Zhang J, Xia Q, Gong X, Xue H, et al. High prevalence of sexually transmitted diseases among men who have sex with men in Jiangsu Province, China. Sex Transm Dis 2006; 33: 118-123.